HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patricia Rousselle Selected Research

laminin 10

5/2011Melanoma cells produce multiple laminin isoforms and strongly migrate on α5 laminin(s) via several integrin receptors.
11/2007Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness: Evidence for a role of alpha5-laminin(s) and alpha3beta1 integrin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patricia Rousselle Research Topics

Disease

6Neoplasms (Cancer)
10/2021 - 11/2007
6Wounds and Injuries (Trauma)
12/2020 - 12/2006
2Inflammation (Inflammations)
10/2022 - 01/2014
2Carcinoma (Carcinomatosis)
01/2022 - 12/2006
1Psoriasis (Pustulosis Palmaris et Plantaris)
10/2022
1Inborn Genetic Diseases (Disease, Hereditary)
01/2022
1Corneal Injuries
01/2020
1Limbal Stem Cell Deficiency
01/2018
1Photophobia (Light Sensitivity)
01/2018
1Pain (Aches)
01/2018
1Skin Neoplasms (Skin Cancer)
11/2017
1Fibrosis (Cirrhosis)
12/2014
1Infections
01/2014
1Bullous Pemphigoid (Pemphigoid)
05/2013
1Pemphigus (Pemphigus Vulgaris)
05/2013
1Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos)
07/2012
1Neoplasm Metastasis (Metastasis)
05/2011
1Melanoma (Melanoma, Malignant)
05/2011
1Carcinogenesis
04/2008
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2008
1Glioma (Gliomas)
11/2007
1Corneal Diseases (Corneal Disease)
06/2007
1Cicatrix (Scar)
06/2007
1Fuchs' Endothelial Dystrophy
06/2007
1Keratoconus
06/2007
1Adenoma (Adenomas)
12/2006
1Adenocarcinoma
12/2006
1Fibrosarcoma
11/2003
1Polycystic Kidney Diseases (Polycystic Kidney Disease)
11/2003
1Cysts
11/2003
1Autosomal Dominant Polycystic Kidney (ADPKD)
11/2003

Drug/Important Bio-Agent (IBA)

6KalininIBA
01/2020 - 11/2003
5Laminin (Merosin)IBA
01/2014 - 06/2007
4IntegrinsIBA
10/2022 - 11/2003
3EnzymesIBA
10/2021 - 12/2006
3Peptides (Polypeptides)IBA
01/2014 - 05/2011
3Protein Isoforms (Isoforms)IBA
05/2011 - 12/2006
2SyndecansIBA
10/2022 - 01/2016
2Syndecan-1 (Syndecan 1)IBA
10/2022 - 12/2020
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2020 - 04/2015
2CytokinesIBA
12/2020 - 04/2015
2CollagenIBA
12/2014 - 07/2012
2laminin 10IBA
05/2011 - 11/2007
2Integrin alpha3beta1IBA
11/2007 - 11/2003
2LigandsIBA
12/2006 - 11/2003
1Fibronectins (Fibronectin)IBA
10/2022
1Biological ProductsIBA
10/2022
1GelatinIBA
10/2022
1Extracellular Matrix ProteinsIBA
01/2022
1Thrombospondin 1IBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Indicators and Reagents (Reagents)IBA
01/2019
1Environmental Pollutants (Pollutants, Environmental)IBA
11/2017
1Cell Surface ReceptorsIBA
01/2016
1AutoantibodiesIBA
05/2013
1ImmunosorbentsIBA
05/2013
1Matrix Metalloproteinases (MMPs)IBA
05/2013
1SaltsIBA
05/2013
1laminin beta2 (S-laminin)IBA
05/2011
1Laminin ReceptorsIBA
11/2007
1Blocking AntibodiesIBA
11/2007
1Matrix Metalloproteinase 7 (Matrilysin)IBA
12/2006
1HCEIBA
12/2006
1Chondroitin Sulfates (Chondroitin Sulfate)IBA
11/2003
1Integrin alpha6beta4IBA
11/2003
1Integrin beta4IBA
11/2003
1Complementary DNA (cDNA)IBA
11/2003

Therapy/Procedure

2Therapeutics
01/2019 - 04/2008
2Corneal Transplantation (Keratoplasty)
01/2018 - 06/2007
1Transplantation
01/2018
1Ligation
11/2003